Home » Archive by Category


San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

HealthFusion’s MediTouch?? EHR Ranked As Top 3 For Clinical Quality And Support In Medical Economics’ National Provider Survey

October 20, 2014 – 5:00 am | Edit Post

SOLANA BEACH, Calif., Oct. 20, 2014 /PRNewswire/ — HealthFusion, maker of MediTouch EHR, the leading cloud computing software for physicians, hospitals, and medical billing services, was ranked as a Top 3 Electronic Health Record (EHR…

As Apple, Offer Egg Freezing, Debate Swirls

October 20, 2014 – 5:00 am | Edit Post

Thermo Fisher Scientific Release: New Digital PCR-Based Research Solution Characterizes Hard-To-Detect Cancer Mutations

October 20, 2014 – 5:00 am | Edit Post

CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific announced today the release of the QuantStudio 3D Rare Mutation Analysis Solution, a panel of wet-lab validated assays combined with an enhanced software tool that enables researchers to detect and quantify 40 of the most common mutations in cancer genes at a prevalence as low as 0.1 percent.Tumor heterogeneity presents a significant…

RainDance Technologies Showcases Leading Genomic Researchers And Novel Sequencing Solutions At American Society of Human Genetics Annual Meeting

October 20, 2014 – 5:00 am | Edit Post

RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetics, today announced the speaker lineup for its upcoming customer workshop at the American Society of Human Genetics (ASHG) Annual Meeting taking place in San Diego, California Oct 18-22, 2014. RainDance will showcase its complete line of products enabling novel, non-invasive Fluid Biopsy applications for…

Halozyme Therapeutics, Inc. Receives FDA Approval For Additional Manufacturing Facilities For Hylenex?? Recombinant

October 20, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 20, 2014 /PRNewswire/ –Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has approved new contract manufacturing facilities used in the production of Hylenexrecombinant (hyaluronidase human injection). The FDA approved…

Scientists Identify Trigger for Crucial Immune System Cell

October 20, 2014 – 12:00 am | Edit Post

The findings from the Teyton lab could lead to novel approaches to diseases such as type 1 diabetes as well as new ways to boost the effectiveness of vaccines.

Scientists Link ALS Progression to Increased Protein Instability

October 20, 2014 – 12:00 am | Edit Post

The research from the Getzoff and Tainer labs suggests a new approach to developing therapies for ALS.

Researchers Receive $6.6 Million to Investigate Deadly Lassa Virus

October 20, 2014 – 12:00 am | Edit Post

The effort, led by the Oldstone lab, aims to uncover how the virus causes disease, as well as why some patients die while others survive.

Snapshot: Dana Scoville

October 20, 2014 – 12:00 am | Edit Post

Meet Dana Scoville of Counseling and Psychological Services, Scripps Florida.

Findings point to an “off switch” for drug resistance in cancer

October 19, 2014 – 5:00 pm | Edit Post

LA JOLLA–Like a colony of bacteria or species of animals, cancer cells within a tumor must evolve to survive. A dose of chemotherapy may kill hundreds of thousands of cancer cells, for example, but a single cell with a unique mutation can survive and quickly generate a new batch of drug-resistant cells, making cancer hard to combat.